References:

1. Robert krisner, Jie Li, Juan Chen. Pathophysiology of acute wound healing. Clin Dermatol. 2006;25(1):9-18.

2. Wolfram D, Tzankov A, Pulzl P, Piza-katzer H.
Hypertrophic scars and keloids: a review of their pathophysiology, risk factors and therapeutic management. Dermatol Surg. 2009;35(2):171-81.

3. Grange PA, Raingeaud J, Calveez V, Dupin N.
Nicotinamide inhibits propionibacterium acnes-induced IL-8 production in kderatinocytes through the NF-kappaB and MAPK pathways. J Dermatol Sci. 2009;56(2):106-12.

4. Martin P, Leibovich SJ. Inflammatory cells during wound healing. Trends Cell Biol. 2005;5(11):599-607.

5. Ferguson MW, OKane S.
Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc B Biol Sci. 2004;359(1445):839-50.

6. Cowin AJ, Holmes TM, Brosnan P, Fergusan MW. Expression of TGF-beta and its receptors in murine fetal and adult thermal wounds. Eur J Dermatol. 2001;11:424-31.

7. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83(3):835-70.

8. Chivot M, Pawin H, Beylot C, et al. Acne scars epidemiology, physiopathology, clinical features and treatment. Ann Dermatol Venereol. 2006;133(10):813-24.

9. Roberts AB, Sporn MB. Transforming growth factor-beta. The Molecular and cellular biology of wound repair. 1996, 275-308.

10. Menke N, Deigelmann RF.
Biochemical pathways of wound healing: Implications for development of disease-specific diagnostics. Advances in Clinical Chemistry. 2006;41:167-87.

11. Soron MB, Komoriya A, Meyers CA, Miller DM.
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification and characterization. J Biol chem. 258:7155-7160, 1983.

12. Roberts AB, Sporn MB. Transforming growth factor-beta. In: The molecular and cellular biolgoy of wound repair(2nd edition), edited by Clark RAF. New York:Plenum, 1996, p. 275-308.

13. Desmouliere A, Gabbiani G.
Transforming growth factor-beta1 induces alpha smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993;122:103-111.

14. Madlener M, Frank S, Werner S.
Transforming frowth factors beta1, beta2, beta3 and their recepotors are differentially regulated during normal and impaired wound healing. J Biol Chem. 1996;271:10188-10193.

15. Bicknell R, Harris AL. Novel angiogenic signaling pathways and vascular targets. Annu Rev Pharmacol Toxicol. 2004;44:219-238.

16. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453:314-321.

17. Werner S, Krieg T, Smola H. Keratinocyte-fibroblast interaction in wound healing. J Invest Dermatol. 2007;127:998-1008.

18. Edward M, et al. Keratinocyte reuglation of TGF-beta and connective tissue growth factor expression: a role in suppression of scar tissue formatio. Wound Repair Regen. 2007;15:748-55.

19. Harvey KA, et al.
Diverse signaling pathways regulate fibroblast differentiation and transformation through Rho kinase activation. J Cell Physiol. 2007;211:353-63.

20. Wakefield LM, Roberts AB. TGF-beta singlaing: Positive and negative effects on tumorigenesis. Curr Opin Genet Dev. 2002;1:22-29.

21. Fabbrocini G, Monfrecola G, et al. Acne scars: pathology, classifications and treatment. Dermatol Res Pract. 2010;893080.

22. Cunliffe WJ, Holland DB, Layton AM, et al.
Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar. Br J Dermatol. 2004;150(1):72-81.

23. Stadelmann WK, Digenis AG, Tobin GR. Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg. 1998;176(2A Suppl):26S-38S.

24. Yamada E, Shimizu M, et al.
Tocoretinate inhibited the contractionof collagen gel matrices by human dermal fibroblasts with tenascin-c expression. J Dermatol Sci. 1999;22(1):45-53.

25. Kilarski WW, Samolov B, Petersson L, Kvanta A, Gerwins P. Biomechanical regualtion of blood vessel growth during tissue vascularization. 2009;15:657-64.

26. Woodley DT, Li W et al.
A traffic control role for TFG-beta3 orchestrating dermal and epidermal cell motility during wound healing. J Cell Biol. 2006;172:1093-1105.

27. Occleston NL, Laverty HG, Ferguson MW.
Prevention and reducation of scarring in the skin by transforming growth factor beta 3: from laboratory discovery to clinical pharmaceutical. J Biomater Sci Polym Ed;200819(8):1047-63.

28. Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and dyanmics of the extracellular matrix. Int J Biochem Cell Bio. 2004;36(6)1031-1037.

29. Tradget EE, Wang JF, Jiao H, Shankowsky HA, et al. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen. 2007;15:113-121.

30. Lee WJ, Jung HJ, et al.
Serial sections of atrophic acne scars help in the interpretation of microscopic findings and the selection of good therapeutic modalities. J Eur Acad Dermatol Venereol. 2011;10:1468-3083.

31. Howard MS. Kent DE, Yug A, Lane JE.
Histologic study of depressed acne scars treated with serial high concentration (95%) tricholoroacetic acid. Dermatol Sur. 2006;32(8):985-90.

* Connoly D. Acne scarring, pathogensis, evaluation and treatment options. J Clin Aesthet Dermatol, 2017 Sep; 10(9):12-23

Pages: 1 2 3